In Berkedrimane B Brevianamid F Citreorosein Cyclo (L-Pro-L-Tyr) Cyclo (L-Pro-L-Val) Cytochalasin

In Berkedrimane B Brevianamid F Citreorosein Cyclo (L-Pro-L-Tyr) Cyclo (L-Pro-L-Val) Cytochalasin D Emodin Ilicicolin B Ilicicolin E Kojic acid Iso-Rhodoptilometrin Macrosporin N-Benzoyl-Phenylalanine Norlichexanthone Oxaline Penicillic acid Physcion Quinolactacin A Skyrin Tryptophol P/N 13/21 10/21 2/21 2/21 9/21 6/21 9/21 21/21 11/21 4/21 4/21 18/21 14/21 21/21 2/21 21/21 14/21 1/21 16/21 17/21 5/21 17/21 8/21 2/21 10/21 17/21 7/21 4/21 20/21 Prevalence 62 48 10 ten 43 29 43 100 52 19 19 86 67 one hundred 10 one hundred 67 five 76 81 24 81 38 10 48 81 33 19 95 Median five.48 11.7 five.ten 161 0.23 two.63 0.41 17.two 0.36 four.39 13.8 eight.33 7.99 16.1 71.5 four.31 28.8 0.39 4160 0.89 0.08 8.29 26.6 13.0 70.5 60.four 0.51 2.50 318 Mean 27.5 13.six five.10 161 0.45 11.5 0.66 283 0.48 18.3 13.5 22.1 15.four 31.6 71.5 7.37 43.6 0.39 20,176 six.00 5.91 66.1 149.7 13.0 333 58.2 0.74 2.67 887 Minimum sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ 0.8 sirtuininhibitorLOQ 1.81 sirtuininhibitorLOQ sirtuininhibitorLOQ six.30 sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ 5.40 sirtuininhibitorLOQ 5.44 0.39 617 0.19 sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ 13.2 sirtuininhibitorLOQ 0.12 sirtuininhibitorLOQ 27.6 Maximum 193 30.six 7.76 300 1.26 55.four 2.07 3998 1.91 64.two 20.0 229 55.three 198 137 34.1 141 0.39 117,815 72.9 29.two 856 1025 25.7 2683 73.RANTES/CCL5 Protein medchemexpress five two.33 four.71 4370 Ra 81.four 53.four 41.six 71.four 60 80.2 54.six 87 85.6 54.2 45 163 90.4 94.6 80.4 121 42.2 76.8 99.six 110 94.2 93.6 65 70 97 98.four 64 79.4 64.four LOD a 0.9 2.eight two.two 13 0.05 0.1 0.1 0.08 0.05 0.two 0.eight 0.8 1.7 1 0.5 0.2 1.three 0.1 75.eight 0.04 0.02 two.3 1.1 0.17 2.5 39 0.03 0.eight 7.08 LOQ b 2.eight 9.two 7.four 44 0.two 0.four 0.four 0.three 0.2 0.7 two.7 two.7 5.six 3.four 1.8 0.eight four.two 0.three 250 0.1 0.05 7.four three.6 0.57 8.1 130 0.1 two.7Calculation of imply, median and variety values was primarily based on good samples. P/N, quantity good samples more than the number of total samples; Ra , apparent recovery; a LOD, limit of detection; b LOQ, limit of quantification.DKK-1 Protein Storage & Stability Table three.PMID:23415682 Overview around the occurrence, concentrations and efficiency characteristics from the analytical method for the detected analytes in sugarcane juice samples.Concentration of Good Samples ( /kg) Detected Analytes 3-Nitropropionic acid Aflatoxin B1 Aflatoxin G1 Agroclavine Ascochlorin Asperglaucide Asperphenamate Aspinolid B Averufin Berkedrimane B Chlorocitreorosein Citreorosein Emodin Fusapyron Fusaric acid Gibberellic acid Griseofulvin Ilicicolin B Kojic acid Integracin A Integracin B Iso-Rhodoptilometrin Monocerin Nidurufin c Norlichexanthone Oxaline P/N 12/40 23/40 7/40 8/40 18/40 7/40 40/40 1/40 27/40 26/40 19/40 35/40 38/40 7/40 12/40 10/40 2/40 35/40 1/40 2/40 2/40 27/40 5/40 14/40 11/40 1/40 Prevalence 30 58 18 20 45 18 100 3 68 65 48 88 95 18 30 25 5 88 3 5 five 68 13 35 28 3 Median two.84 0.56 0.ten three.05 0.22 0.03 five.23 7.92 0.12 0.41 3.26 1.28 0.45 0.98 67.9 two.30 0.36 0.59 208 1.73 1.12 0.03 0.28 0.ten 0.84 1.61 Imply 3.58 0.72 0.30 three.96 0.28 0.21 12.five 7.92 0.13 5.75 8.65 1.99 0.82 7.49 258 18.7 0.36 2.44 208 1.73 1.19 0.06 1.26 0.15 1.67 1.61 Minimum sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ 0.65 7.92 sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ sirtuininhibitorLOQ 25.four sirtuininhibitorLOQ 0.20 sirtuininhibitorLOQ 208 1.60 sirtuininhibit.